Farallon Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ZEN
ZENDESK INC
ZEN
|
+$262M |
| 2 |
Clarivate
CLVT
|
+$202M |
| 3 |
CHNG
Change Healthcare Inc. Common Stock
CHNG
|
+$196M |
| 4 |
S&P Global
SPGI
|
+$139M |
| 5 |
Humana
HUM
|
+$122M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COHR
Coherent Inc
COHR
|
+$154M |
| 2 |
Howmet Aerospace
HWM
|
+$140M |
| 3 |
CoStar Group
CSGP
|
+$139M |
| 4 |
Boston Scientific
BSX
|
+$116M |
| 5 |
MANT
Mantech International Corp
MANT
|
+$92.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 28.39% |
| 2 | Technology | 19.07% |
| 3 | Miscellaneous | 16.73% |
| 4 | Financials | 13.73% |
| 5 | Industrials | 8.28% |
Similar funds
Farallon Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Farallon Capital Management held 333 positions worth $18.2B, down 1.3% from $18.4B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Farallon Capital Management withdrew a net $871M in Q3 2022, closing 22 positions and reducing 36 holdings. Its most notable exit was Coherent Inc, an estimated $154M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 28% of assets, down from 31% a quarter earlier, followed by Technology and Miscellaneous.
Against the trend, Farallon Capital Management opened a new position in Humana worth $122M.
- Farallon Capital Management's largest Q3 2022 buy was Humana: 251,200 shares worth $122M.
- Farallon Capital Management added most to ZENDESK INC in Q3 2022, an estimated $262M increase.
- Farallon Capital Management's biggest Q3 2022 reduction was Howmet Aerospace, cutting an estimated $140M.
- Farallon Capital Management fully exited Coherent Inc in Q3 2022, selling an estimated $154M.
- Farallon Capital Management's ten largest holdings make up 32% of its $18.2B portfolio in Q3 2022.
- Farallon Capital Management opened 17 new positions and closed 22 in Q3 2022.
- Farallon Capital Management's portfolio value fell 1.3% quarter-over-quarter to $18.2B.
Based on Farallon Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.